908 Devices/MASS

$5.79

-4.61%
-
1D1W1MYTD1YMAX

About 908 Devices

908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.

Ticker

MASS

Sector

Healthcare

Trading on

NASDAQ

Industry

Scientific & Technical Instr.

CEO

Kevin Knopp

Employees

230

Headquarters

Boston, United States

908 Devices Metrics

BasicAdvanced
$199.76M
Market cap
-
P/E ratio
-$1.13
EPS
0.98
Beta
-
Dividend rate
$199.76M
0.9768
$12.51
$4.85
162.41K
7.707
7.045
-16.34%
-20.44%
-18.03%
3.977
1.193
1.357
7.21%
-5.97%
23.15%

What the Analysts think about 908 Devices

Analyst Ratings

Majority rating from 5 analysts.
Buy

Price Targets

Average projection from 3 analysts.
164.77% upside
High $17.00
Low $14.00
$5.79
Current price
$15.33
Average price target

908 Devices Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-51.74% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$14.3M
0.7%
Net income
$-7.4M
5.71%
Profit margin
-51.74%
4.97%

908 Devices Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 12.88%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.39
-$0.29
-$0.22
-$0.23
-
Expected
-$0.35
-$0.35
-$0.30
-$0.26
-$0.37
Surprise
12.72%
-16.67%
-27.15%
-12.88%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for 908 Devices stock?

908 Devices (MASS) has a market cap of $199.76M as of April 16, 2024.

What is the P/E ratio for 908 Devices stock?

The price to earnings (P/E) ratio for 908 Devices (MASS) stock is 0 as of April 16, 2024.

Does 908 Devices stock pay dividends?

No, 908 Devices (MASS) stock does not pay dividends to its shareholders as of April 16, 2024.

When is the next 908 Devices dividend payment date?

908 Devices (MASS) stock does not pay dividends to its shareholders.

What is the beta indicator for 908 Devices?

908 Devices (MASS) has a beta rating of 0.98. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the 908 Devices stock price target?

The target price for 908 Devices (MASS) stock is $15.33, which is 164.77% above the current price of $5.79. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell 908 Devices stock

Buy or sell 908 Devices stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing